Trial NCT01807156

View at ClinicalTrials.gov 
Org. Study IDs: IRB00061422
Secondary IDs: IRB00061422 WINSHIP2302-12

Last trial update was posted on 2016-04-22

MeSH Interventions

Tivozanib

MeSH Conditions

Carcinoma, Hepatocellular Liver Neoplasms

Other Conditions

Hepatocellular Cancer

Stopping Reasons

Primary endpoint not met

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID